Calendar

Financial Releases

Date Title  
Toggle Summary AbbVie to Present at the Barclays Global Healthcare Conference
NORTH CHICAGO, Ill. , March 1, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Barclays Global Healthcare Conference on Wednesday, March 13, 2019 . Michael Severino , vice chairman and president, will present at 9:15 a.m.
Toggle Summary AbbVie to Present at the Cowen Health Care Conference
NORTH CHICAGO, Ill. , Feb. 28, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the 39 th Annual Cowen Health Care Conference on Tuesday, March 12, 2019 . Richard A. Gonzalez , chairman and chief executive officer, will present at 7:00
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill. , Feb. 21, 2019 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE:ABBV) declared a quarterly cash dividend of $1.07 per share. The cash dividend is payable May 15, 2019 to stockholders of record at the close of business on April 15, 2019 .
Toggle Summary AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results
- Reports Full-Year Diluted EPS of $3.66 on a GAAP Basis; Adjusted Diluted EPS of $7.91 Reflects Growth of 41.3 Percent - Delivers Full-Year Net Revenues of $32.753 Billion on a GAAP Basis; Adjusted Net Revenues of $32.733 Billion Increased 15.2 Percent on an Operational Basis - Full-Year Global
Toggle Summary AbbVie to Host Fourth-Quarter and Full-Year 2018 Earnings Conference Call
NORTH CHICAGO, Ill. , Jan. 3, 2019 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will announce its fourth-quarter and full-year 2018 financial results on Friday, January 25, 2019 before the market opens. AbbVie will host a live webcast of the earnings
Toggle Summary AbbVie to Present at the 37th Annual J.P. Morgan Healthcare Conference
NORTH CHICAGO, Ill. , Dec. 20, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the 37 th annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019 . Michael Severino , M.D., Vice Chairman and President, will present at
Toggle Summary AbbVie Announces Executive Leadership Changes
NORTH CHICAGO, Ill. , Dec. 17, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced a new Executive Leadership Team structure designed to streamline its organizational structure and support its long-term growth strategy.  Effective
Toggle Summary AbbVie Announces $5 Billion Increase to Stock Repurchase Program
NORTH CHICAGO, Ill. , Dec. 13, 2018 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) has authorized a $5 billion increase to AbbVie's existing stock repurchase program. Purchases may be made from time to time at management's discretion.
Toggle Summary AbbVie to Present at the Evercore ISI Conference
NORTH CHICAGO, Ill. , Nov. 13, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Evercore ISI HealthConX Conference on Tuesday, November 27, 2018. Bill Chase , executive vice president, finance and administration, will present at 8
Toggle Summary AbbVie Reports Third-Quarter 2018 Financial Results
- Reports Third-Quarter Diluted EPS of $1.81 on a GAAP Basis; Adjusted Diluted EPS of $2.14 Reflects Growth of 51.8 Percent - Delivers Third-Quarter Net Revenues of $8.236 Billion on a GAAP Basis; Adjusted Net Revenues of $8.236 Billion Increased 18.5 Percent on an Operational Basis - Third-Quarter